FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2496438474> ?p ?o ?g. }

• W2496438474 abstract "Trafficking and expansion of myeloid derived suppressor cells (MDSCs) plays a major role in the immune suppression of tumors. MDSCs express chemokine receptors which likely mediate their recruitment to the tumor microenvironment. Suppression of T cells is also mediated by the interaction of programmed death-1 (PD-1) and its ligands which are abundantly expressed in cancer cells and immune infiltrates, including MDSCs. Here, we show that targeting both pathways through administration of a small molecule chemokine receptor antagonist (CCX9588, which blocks CCR1) and a PD-L1 monoclonal antibody (mAb) significantly reduced tumor burden in mice who received orthotopic transplants of 4T1 cells, a cell line used to model triple negative breast cancer. Primary tumor growth was modestly reduced by either agent (PD-L1 mAb or CCR1 inhibitor) alone, but the combination of CCR1 inhibitor plus PD-L1 mAb resulted in significantly reduced tumor progression as compared to either of the single agents. Furthermore, lung metastasis was also significantly reduced by CCR1 antagonist and combination treatment. Orthotropic 4T1 cell engraftment induced robust expansion of CD11b+Ly6Ghi Ly6Chi MDSCs, a subpopulation of which express CCR1. Analysis of the tumor infiltrating cells revealed that CCX9588 significantly reduced the number of MDSCs and increased CD8 T cells infiltration in primary tumors, suggesting that CCR1 blockade of MDSC trafficking in combination with PD-L1 mAb translates into reduced tumor burden, possibly through increased CD8 T cell response against the tumor. Analysis of human breast cancer patient samples from The Cancer Genome Atlas (TCGA) database revealed that the CCR1 ligands, MCP-7 (CCL7) and RANTES (CCL5) are present at significantly higher levels in breast cancers as compared to normal breast tissue. Interestingly, ligands for CCR1 and PD-1 are significantly higher in triple negative breast cancer samples than in the other breast cancer subtypes. These data are the first to show that CCR1 chemokine receptor antagonists can act synergistically with PDL-1 inhibitors, and suggest a novel approach for potentiating the activity of immune cell checkpoint inhibitors in one of the most aggressive forms of breast cancer. Citation Format: Heiyoun Jung, Linda Ertl, Karen Ebsworth, Christine Janson, Penglie Zhang, Punna Sreenivas, Thomas Schall, Israel Charo. Combination therapy of chemokine receptor inhibition plus PD-L1 blockade potentiates antitumor effects in a murine model of breast cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 564." @default.
• W2496438474 created "2016-08-23" @default.
• W2496438474 creator A5013663540 @default.
• W2496438474 creator A5015756622 @default.
• W2496438474 creator A5037473768 @default.
• W2496438474 creator A5044899702 @default.
• W2496438474 creator A5055939902 @default.
• W2496438474 creator A5061412536 @default.
• W2496438474 creator A5078844354 @default.
• W2496438474 creator A5082488310 @default.
• W2496438474 date "2016-07-15" @default.
• W2496438474 modified "2023-09-27" @default.
• W2496438474 title "Abstract 564: Combination therapy of chemokine receptor inhibition plus PD-L1 blockade potentiates antitumor effects in a murine model of breast cancer" @default.
• W2496438474 doi "https://doi.org/10.1158/1538-7445.am2016-564" @default.
• W2496438474 hasPublicationYear "2016" @default.
• W2496438474 type Work @default.
• W2496438474 sameAs 2496438474 @default.
• W2496438474 citedByCount "0" @default.
• W2496438474 crossrefType "proceedings-article" @default.
• W2496438474 hasAuthorship W2496438474A5013663540 @default.
• W2496438474 hasAuthorship W2496438474A5015756622 @default.
• W2496438474 hasAuthorship W2496438474A5037473768 @default.
• W2496438474 hasAuthorship W2496438474A5044899702 @default.
• W2496438474 hasAuthorship W2496438474A5055939902 @default.
• W2496438474 hasAuthorship W2496438474A5061412536 @default.
• W2496438474 hasAuthorship W2496438474A5078844354 @default.
• W2496438474 hasAuthorship W2496438474A5082488310 @default.
• W2496438474 hasConcept C121608353 @default.
• W2496438474 hasConcept C126322002 @default.
• W2496438474 hasConcept C12823836 @default.
• W2496438474 hasConcept C129013479 @default.
• W2496438474 hasConcept C13373296 @default.
• W2496438474 hasConcept C167672396 @default.
• W2496438474 hasConcept C203014093 @default.
• W2496438474 hasConcept C2776107976 @default.
• W2496438474 hasConcept C2779013556 @default.
• W2496438474 hasConcept C502942594 @default.
• W2496438474 hasConcept C71924100 @default.
• W2496438474 hasConcept C8891405 @default.
• W2496438474 hasConceptScore W2496438474C121608353 @default.
• W2496438474 hasConceptScore W2496438474C126322002 @default.
• W2496438474 hasConceptScore W2496438474C12823836 @default.
• W2496438474 hasConceptScore W2496438474C129013479 @default.
• W2496438474 hasConceptScore W2496438474C13373296 @default.
• W2496438474 hasConceptScore W2496438474C167672396 @default.
• W2496438474 hasConceptScore W2496438474C203014093 @default.
• W2496438474 hasConceptScore W2496438474C2776107976 @default.
• W2496438474 hasConceptScore W2496438474C2779013556 @default.
• W2496438474 hasConceptScore W2496438474C502942594 @default.
• W2496438474 hasConceptScore W2496438474C71924100 @default.
• W2496438474 hasConceptScore W2496438474C8891405 @default.
• W2496438474 hasLocation W24964384741 @default.
• W2496438474 hasOpenAccess W2496438474 @default.
• W2496438474 hasPrimaryLocation W24964384741 @default.
• W2496438474 hasRelatedWork W1513588586 @default.
• W2496438474 hasRelatedWork W1999914504 @default.
• W2496438474 hasRelatedWork W2312937143 @default.
• W2496438474 hasRelatedWork W2400157110 @default.
• W2496438474 hasRelatedWork W2400532621 @default.
• W2496438474 hasRelatedWork W2535500972 @default.
• W2496438474 hasRelatedWork W2604910109 @default.
• W2496438474 hasRelatedWork W2742057624 @default.
• W2496438474 hasRelatedWork W2804202166 @default.
• W2496438474 hasRelatedWork W2954076813 @default.
• W2496438474 hasRelatedWork W2954101464 @default.
• W2496438474 hasRelatedWork W2955094798 @default.
• W2496438474 hasRelatedWork W2997058272 @default.
• W2496438474 hasRelatedWork W3011277031 @default.
• W2496438474 hasRelatedWork W3030763890 @default.
• W2496438474 hasRelatedWork W3034775828 @default.
• W2496438474 hasRelatedWork W3134641697 @default.
• W2496438474 hasRelatedWork W3212428829 @default.
• W2496438474 hasRelatedWork W4226287797 @default.
• W2496438474 hasRelatedWork W3106914487 @default.
• W2496438474 isParatext "false" @default.
• W2496438474 isRetracted "false" @default.
• W2496438474 magId "2496438474" @default.
• W2496438474 workType "article" @default.